IDH1 and central nervous system cancer: To evaluate other alterations on the assay additional non-glioma specimens with IDH1 p. R132L (n = 1), IDH2 p.R140Q (n = 1), IDH2 p.R172G (n = 3), and IDH2 p.R172W (n = 3) were also tested.